IL154602A0 - Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof - Google Patents

Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof

Info

Publication number: IL154602A0
Authority: IL; Israel
Prior art keywords: compounds; production; methods; medicaments containing; bicyclic heterocycles
Prior art date: 2000-08-26

Application number

IL15460201A

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-26

Filing date

2001-08-18

Publication date

2003-09-17

2001-08-18 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-09-17 Publication of IL154602A0 publication Critical patent/IL154602A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL15460201A 2000-08-26 2001-08-18 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof IL154602A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10042058A DE10042058A1 (en)	2000-08-26	2000-08-26	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
PCT/EP2001/009532 WO2002018351A1 (en)	2000-08-26	2001-08-18	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof

Publications (1)

Publication Number	Publication Date
IL154602A0 true IL154602A0 (en)	2003-09-17

Family

ID=7653945

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15460201A IL154602A0 (en)	2000-08-26	2001-08-18	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
IL154602A IL154602A (en)	2000-08-26	2003-02-24	Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL154602A IL154602A (en)	2000-08-26	2003-02-24	Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases

Country Status (31)

Country	Link
EP (1)	EP1315705A1 (en)
JP (1)	JP4834282B2 (en)
KR (1)	KR100862873B1 (en)
CN (1)	CN100404517C (en)
AR (1)	AR033562A1 (en)
AU (2)	AU2001287694B2 (en)
BG (1)	BG107559A (en)
BR (1)	BR0113519A (en)
CA (1)	CA2417897C (en)
CZ (1)	CZ302567B6 (en)
DE (1)	DE10042058A1 (en)
EA (1)	EA005679B1 (en)
EC (1)	ECSP034464A (en)
EE (1)	EE05269B1 (en)
HK (1)	HK1057557A1 (en)
HR (1)	HRP20030138A2 (en)
HU (1)	HUP0300819A3 (en)
IL (2)	IL154602A0 (en)
ME (1)	MEP58708A (en)
MX (1)	MXPA03001483A (en)
MY (1)	MY126132A (en)
NO (1)	NO324866B1 (en)
NZ (1)	NZ524668A (en)
PL (1)	PL360248A1 (en)
RS (1)	RS52279B (en)
SK (1)	SK287747B6 (en)
TW (1)	TWI294422B (en)
UA (1)	UA73004C2 (en)
UY (1)	UY26903A1 (en)
WO (1)	WO2002018351A1 (en)
ZA (1)	ZA200300991B (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU90901A (en)	1999-06-21	2004-07-15	Boehringer Ingelheim Pharma Gmbh. & Co.Kg.	Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
DE10042059A1 (en) *	2000-08-26	2002-03-07	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
TWI324597B (en) *	2002-03-28	2010-05-11	Astrazeneca Ab	Quinazoline derivatives
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
EP1492536B1 (en) *	2002-03-30	2012-05-09	Boehringer Ingelheim Pharma GmbH & Co.KG	4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
DE10214412A1 (en) *	2002-03-30	2003-10-09	Boehringer Ingelheim Pharma	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and process for their preparation
EP1521747B1 (en)	2002-07-15	2018-09-05	Symphony Evolution, Inc.	Receptor-type kinase modulators and methods of use
DE10326186A1 (en) *	2003-06-06	2004-12-23	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10334226A1 (en) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
EP1667992B1 (en)	2003-09-19	2007-01-24	Astrazeneca AB	Quinazoline derivatives
PT2210607E (en)	2003-09-26	2012-01-31	Exelixis Inc	N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-n`-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
DE10345875A1 (en) *	2003-09-30	2005-04-21	Boehringer Ingelheim Pharma	Bicyclic heterocycles, pharmaceutical compositions containing them, their use and methods of preparation
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10350717A1 (en) *	2003-10-30	2005-06-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (en)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
AR055564A1 (en)	2005-02-26	2007-08-22	Astrazeneca Ab	QUINAZOLINE DERIVATIVES
KR100673775B1 (en) *	2005-04-08	2007-01-24	엘지전자 주식회사	Refrigerator Home Bar
US20100234371A1 (en) *	2005-08-22	2010-09-16	Frank Himmelsbach	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof
JP5688877B2 (en)	2005-11-11	2015-03-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Quinazoline derivatives for the treatment of cancer diseases
EP1996561A1 (en) *	2006-03-09	2008-12-03	Boehringer Ingelheim International GmbH	Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
JP2010503717A (en)	2006-09-18	2010-02-04	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Methods for treating tumors with EGFR mutations
EP1921070A1 (en)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
US7998949B2 (en)	2007-02-06	2011-08-16	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
ME01461B (en)	2008-02-07	2014-04-20	Boehringer Ingelheim Int	Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
BRPI0912170A2 (en)	2008-05-13	2015-10-13	Astrazeneca Ab	compound, form, process for preparation thereof, pharmaceutical composition, use of a compound, and method for treating cancer in a warm-blooded animal
WO2010015522A1 (en)	2008-08-08	2010-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof
US8877776B2 (en)	2009-01-16	2014-11-04	Exelixis, Inc.	(L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
HUE044629T2 (en)	2009-07-06	2019-11-28	Boehringer Ingelheim Int	Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
UA108618C2 (en)	2009-08-07	2015-05-25		APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
KR101317809B1 (en)	2011-06-07	2013-10-16	한미약품 주식회사	Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cell and non-metalic salt lubricant
KR20140096571A (en)	2013-01-28	2014-08-06	한미약품 주식회사	Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
LT2964638T (en)	2013-03-06	2017-12-27	Astrazeneca Ab	Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
UA119166C2 (en) *	2014-04-04	2019-05-10	Х. Луннбек А/С	HALOGENATED HINAZOLINE-THF-AMINES AS PDE1 INHIBITORS
US20170176028A1 (en)	2015-12-18	2017-06-22	Lg Electronics Inc.	Air conditioner
US11446302B2 (en)	2016-11-17	2022-09-20	Board Of Regents, The University Of Texas System	Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations
CN112321814B (en) *	2020-12-30	2021-03-23	广州初曲科技有限公司	Preparation and application of gefitinib idebenone conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9508538D0 (en) *	1995-04-27	1995-06-14	Zeneca Ltd	Quinazoline derivatives
GB9624482D0 (en) *	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
HUP9901155A3 (en) *	1996-02-13	2003-04-28	Astrazeneca Ab	Quinazoline derivatives as vegf inhibitors
GB9603095D0 (en) *	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline derivatives
AU719327B2 (en) *	1996-03-05	2000-05-04	Astrazeneca Ab	4-anilinoquinazoline derivatives
DE69710712T3 (en) *	1996-04-12	2010-12-23	Warner-Lambert Co. Llc	REVERSIBLE INHIBITORS OF TYROSINE KINASEN
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
DE19911509A1 (en) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation

2000
- 2000-08-26 DE DE10042058A patent/DE10042058A1/en not_active Ceased
2001
- 2001-08-18 CN CNB01814635XA patent/CN100404517C/en not_active Expired - Fee Related
- 2001-08-18 HU HU0300819A patent/HUP0300819A3/en unknown
- 2001-08-18 JP JP2002523469A patent/JP4834282B2/en not_active Expired - Fee Related
- 2001-08-18 EA EA200300219A patent/EA005679B1/en not_active IP Right Cessation
- 2001-08-18 CA CA002417897A patent/CA2417897C/en not_active Expired - Fee Related
- 2001-08-18 AU AU2001287694A patent/AU2001287694B2/en not_active Ceased
- 2001-08-18 PL PL36024801A patent/PL360248A1/en not_active Application Discontinuation
- 2001-08-18 AU AU8769401A patent/AU8769401A/en active Pending
- 2001-08-18 KR KR1020037002744A patent/KR100862873B1/en not_active IP Right Cessation
- 2001-08-18 RS YU14003A patent/RS52279B/en unknown
- 2001-08-18 WO PCT/EP2001/009532 patent/WO2002018351A1/en active Application Filing
- 2001-08-18 UA UA2003032533A patent/UA73004C2/en unknown
- 2001-08-18 CZ CZ20030870A patent/CZ302567B6/en not_active IP Right Cessation
- 2001-08-18 MX MXPA03001483A patent/MXPA03001483A/en active IP Right Grant
- 2001-08-18 EP EP01967285A patent/EP1315705A1/en not_active Ceased
- 2001-08-18 BR BR0113519-8A patent/BR0113519A/en active Pending
- 2001-08-18 SK SK231-2003A patent/SK287747B6/en not_active IP Right Cessation
- 2001-08-18 ME MEP-587/08A patent/MEP58708A/en unknown
- 2001-08-18 IL IL15460201A patent/IL154602A0/en unknown
- 2001-08-18 EE EEP200300077A patent/EE05269B1/en not_active IP Right Cessation
- 2001-08-18 NZ NZ524668A patent/NZ524668A/en not_active IP Right Cessation
- 2001-08-23 UY UY26903A patent/UY26903A1/en not_active Application Discontinuation
- 2001-08-24 MY MYPI20013985A patent/MY126132A/en unknown
- 2001-08-24 TW TW090120905A patent/TWI294422B/en not_active IP Right Cessation
- 2001-08-24 AR ARP010104041A patent/AR033562A1/en not_active Suspension/Interruption
2003
- 2003-02-03 EC EC2003004464A patent/ECSP034464A/en unknown
- 2003-02-05 ZA ZA200300991A patent/ZA200300991B/en unknown
- 2003-02-14 BG BG107559A patent/BG107559A/en active Pending
- 2003-02-24 IL IL154602A patent/IL154602A/en not_active IP Right Cessation
- 2003-02-24 HR HR20030138A patent/HRP20030138A2/en not_active Application Discontinuation
- 2003-02-25 NO NO20030870A patent/NO324866B1/en not_active IP Right Cessation
2004
- 2004-01-21 HK HK04100462A patent/HK1057557A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
MEP58708A (en)	2011-05-10
AU2001287694B2 (en)	2007-09-06
JP4834282B2 (en)	2011-12-14
TWI294422B (en)	2008-03-11
NO20030870L (en)	2003-02-25
RS52279B (en)	2012-10-31
UY26903A1 (en)	2002-03-22
AU8769401A (en)	2002-03-13
ZA200300991B (en)	2004-04-16
EE200300077A (en)	2004-12-15
CA2417897C (en)	2009-03-31
EE05269B1 (en)	2010-02-15
MY126132A (en)	2006-09-29
CA2417897A1 (en)	2003-01-30
PL360248A1 (en)	2004-09-06
CZ302567B6 (en)	2011-07-13
CN100404517C (en)	2008-07-23
EP1315705A1 (en)	2003-06-04
HRP20030138A2 (en)	2005-04-30
NO20030870D0 (en)	2003-02-25
KR100862873B1 (en)	2008-10-15
YU14003A (en)	2006-01-16
ECSP034464A (en)	2003-03-31
DE10042058A1 (en)	2002-03-07
MXPA03001483A (en)	2003-06-06
SK2312003A3 (en)	2003-10-07
NO324866B1 (en)	2007-12-17
JP2004507529A (en)	2004-03-11
IL154602A (en)	2008-07-08
WO2002018351A1 (en)	2002-03-07
BR0113519A (en)	2003-07-01
EA005679B1 (en)	2005-04-28
SK287747B6 (en)	2011-08-04
UA73004C2 (en)	2005-05-16
HK1057557A1 (en)	2004-04-08
EA200300219A1 (en)	2003-08-28
CN1449390A (en)	2003-10-15
AR033562A1 (en)	2003-12-26
HUP0300819A3 (en)	2008-03-28
KR20030024914A (en)	2003-03-26
NZ524668A (en)	2006-06-30
HUP0300819A2 (en)	2003-09-29
BG107559A (en)	2003-10-31

Publication	Publication Date	Title
HK1057557A1 (en)	2004-04-08	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
IL147133A0 (en)	2002-08-14	Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
AU2001295481A1 (en)	2002-03-13	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
AU2001287694A1 (en)	2002-06-06	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
IL156552A0 (en)	2004-01-04	Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
HRP20030501A2 (en)	2005-04-30	Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU6383101A (en)	2001-10-23	Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
MXPA03000873A (en)	2003-06-06	Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof.
HUS1400005I1 (en)	2017-08-28	Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
MXPA03001510A (en)	2003-06-09	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof.
HUP0401081A3 (en)	2010-06-28	Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
HUP0401329A2 (en)	2004-12-28	Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
AU2002219173A1 (en)	2002-09-05	Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
HK1044338A1 (en)	2002-10-18	5-Pyridyl-1, 3-azole compounds, process for producing the same and use thereof
HUP0300002A3 (en)	2006-01-30	Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
AU2003226806A1 (en)	2003-11-03	Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
AU2001241056A1 (en)	2001-09-17	Spiro compounds, process for preparing the same and use thereof as drugs
HUP0302648A3 (en)	2004-11-29	Bicyclic heteroaromatic compounds, pharmaceutical compositions containing them and their use
ZA200110351B (en)	2002-06-18	Bycyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof.
HU0001178D0 (en)	2000-06-28	New propene-carbon acid-amidoxim derivatives, process for their production and medicaments containing the same

Legal Events

Date	Code	Title	Description
2009-06-15	KB	Patent renewed